Keyword Connections

glioma

Journals

20

1 Scientific reports

2 International journal of molecular sciences

3 Journal of colloid and interface science

4 Cells

5 journal of neuro-oncology

6 European radiology

7 BMC cancer

8 journal of neurosurgery

9 neuroimage clinical

10 acta neuropathologica

11 journal of cellular physiology

12 cancer cell international

13 experimental cell research

14 bmc medical genomics

15 The International journal of neuroscience

16 Pneumologie

17 Frontiers in cell and developmental biology

18 swiss medical weekly

19 current opinion in neurology

20 fundamental & clinical pharmacology

Research Groups

0

No Research Group Connected

Bibliographies

208

1 An update on the CNS manifestations of neurofibromatosis type 2.

2 Peripheral vestibular disorders: an update.

3 Dizziness in the emergency department: an update on diagnosis.

4 The effects of melatonin on signaling pathways and molecules involved in glioma.

5 Metabolic Reprogramming in Glioma.

6 Spatial distribution of malignant transformation in patients with low-grade glioma.

7 Enhancing selective photosensitizer accumulation and oxygen supply for high-efficacy photodynamic therapy toward glioma by 5-aminolevulinic acid loaded nanoplatform.

8 Long noncoding RNA SNHG17 induced by YY1 facilitates the glioma progression through targeting miR-506-3p/CTNNB1 axis to activate Wnt/β-catenin signaling pathway.

9 Arg kinase mediates CXCL12/CXCR4-induced invadopodia formation and invasion of glioma cells.

10 Quantification and visualization of lipid landscape in glioma using in -and opposed-phase imaging.

11 Eslicarbazepine in Patients with Brain Tumor-Related Epilepsy: A Single-Center Experience.

12 frequency of epstein-barr virus dna sequences in human gliomas

13 proton magnetic resonance spectroscopy and apparent diffusion coefficient in evaluation of solid brain lesions

14 neuroimaging of adult gliomas: an update

15 immune-checkpoint blockade and active immunotherapy for glioma

16 leveraging ethnic group incidence variation to investigate genetic susceptibility to glioma: a novel candidate snp approach

17 sevoflurane regulates glioma progression by circ_0002755/mir-628-5p/magt1 axis

18 bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern

19 inhibition of tumor growth, angiogenesis, and microcirculation by the novel flk-1 inhibitor su5416 as assessed by intravital multi-fluorescence videomicroscopy

20 an overview of therapeutic approaches to brain tumor stem cells

21 comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric mri

22 epstein–barr virus in gliomas: cause, association, or artifact?

23 cellular high-energy cavitation trauma - description of a novel in vitro trauma model in three different cell types.

24 the usefulness of arcuate fasciculus tractography integrated navigation for glioma surgery near the language area; clinical investigation

25 correlation of mir-221 expression with pten/akt signal pathway and emt-related gene expression in glioma tissue

26 the controversy about a possible relationship between mobile phone use and cancer a controvérsia sobre a possível relação entre o uso do telefone celular e câncer

27 emerging insights into barriers to effective brain tumor therapeutics

28 positive expression of kif20a indicates poor prognosis of glioma patients

29 metabolomics of therapy response in preclinical glioblastoma: a multi-slice mrsi-based volumetric analysis for noninvasive assessment of temozolomide treatment

30 the use of convection-enhanced delivery with liposomal toxins in neurooncology

31 anti-inflammatory and antitumor effects of hydroxytyrosol but not oleuropein on experimental glioma in vivo. a putative role for the renin-angiotensin system

32 role of akt isoforms controlling cancer stem cell survival, phenotype and self-renewal

33 immunosuppressive mechanisms of malignant gliomas: parallels at non-cns sites

34 new trends in cancer therapy: targeting ion channels and transporters

35 the tyrosine kinase pyk2 promotes migration and invasion of glioma cells

36 remodeling the blood–brain barrier microenvironment by natural products for brain tumor therapy

37 microrna in human glioma

38 analysis of mammalian septin expression in human malignant brain tumors

39 genetically engineered multilineage-differentiating stress-enduring cells as cellular vehicles against malignant gliomas

40 up-regulation of long non-coding rna ab073614 predicts a poor prognosis in patients with glioma

41 advanced mri increases the diagnostic accuracy of recurrent glioblastoma: single institution thresholds and validation of mr spectroscopy and diffusion weighted mr imaging

42 Abstracts from the 2012 BNOS Conference

43 Glioma Surgical Aspirate: A Viable Source of Tumor Tissue for Experimental Research

44 CHRDL1 Regulates Stemness in Glioma Stem-like Cells.

45 [Test Your Knowledge].

46 Gene Expression of /CD114 Is Associated with Poorer Patient Survival in Glioma.

47 A proof-of-principle for decontamination of transplantation kidney through UV-C exposition of the perfusate solution.

48 Flavonoids inhibit angiogenic cytokine production by human glioma cells.

49 Extraneural Metastasis of Primary Glioma Occurring in a Setting of Occupational Ionizing Radiation Exposure

50 Carotid Paraganglioma in Adolescence-Clinical Picture-Surgical Technique and Review of the Literature

51 Usefulness of positron emission tomography for differentiating gliomas according to the 2016 World Health Organization classification of tumors of the central nervous system.

52 Conditioned Media from Human Adipose Tissue-Derived Mesenchymal Stem Cells and Umbilical Cord-Derived Mesenchymal Stem Cells Efficiently Induced the Apoptosis and Differentiation in Human Glioma Cell Lines In Vitro

53 Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.

54 Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier.

55 Overall survival in malignant glioma is significantly prolonged by neurosurgical delivery of etoposide and temozolomide from a thermo-responsive biodegradable paste

56 Tumor border sharpness correlates with HLA-G expression in low-grade gliomas.

57 Stoichioproteomics reveal oxygen usage bias, key proteins and pathways in glioma.

58 Long Intergenic Non-coding RNA Profiles of Pheochromocytoma and Paraganglioma: A Novel Prognostic Biomarker.

59 A negative feedback loop of H19/miR-675/VDR mediates therapeutic effect of cucurmin in the treatment of glioma.

60 Publisher Correction: Mendelian randomisation study of the relationship between vitamin D and risk of glioma (Scientific Reports, (2018), 8, 1, (2339), 10.1038/s41598-018-20844-w)

61 Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment

62 The effect of marital status on glioma patient survival: analysis of 617 cases: A SEER-based study.

63 Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein.

64 FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas.

65 Author Correction: Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition (Cell Death Discovery, (2019), 5, 1, (72), 10.1038/s41420-019-0155-9)

66 Lactoferrin-coated polysaccharide nanoparticles based on chitosan hydrochloride/hyaluronic acid/PEG for treating brain glioma

67 GOLGA7 rs11337, a Polymorphism at the MicroRNA Binding Site, Is Associated with Glioma Prognosis.

68 Predicting the 1p/19q co-deletion status of presumed low grade glioma with an externally validated machine learning algorithm.

69 Impact of facility type and volume in low-grade glioma outcomes.

70 Transcriptional alterations in glioma result primarily from DNA methylation-independent mechanisms.

71 Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines.

72 Comparison of 5-aminolevulinic acid and sodium fluorescein for intraoperative tumor visualization in patients with high-grade gliomas: a single-center retrospective study.

73 Pediatric ganglioglioma of the brainstem and cervicomedullary junction: a retrospective cohort study.

74 Preimplantation genetic diagnosis for a single gene mutation for succinate dehydrogenase subunit B (the genetic basis for malignant paraganglioma) with successful pregnancy

75 PI3K/mTOR inhibition of IDH1 mutant glioma leads to reduced 2HG production that is associated with increased survival

76 Targeted brain delivery nanoparticles for malignant gliomas.

77 A Novel Deep Learning Algorithm for the Automatic Detection of High-Grade Gliomas on T2-Weighted Magnetic Resonance Images: A Preliminary Machine Learning Study.

78 Outcome Prediction for Patient with High-Grade Gliomas from Brain Functional and Structural Networks.

79 HDAC inhibition induces expression of scaffolding proteins critical for tumor progression in pediatric glioma: focus on EBP50 and IRSp53.

80 Advanced imaging in adult diffusely infiltrating low-grade gliomas.

81 Author Correction: The role of the SWI/SNF chromatin remodeling complex in maintaining the stemness of glioma initiating cells

82 Low Expression of CAPON in Glioma Contributes to Cell Proliferation via the Akt Signaling Pathway

83 Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program

84 Pyrazolopyrimide library screening in glioma cells discovers highly potent antiproliferative leads that target the PI3K/mTOR pathway.

85 Glioma Mimics: Magnetic Resonance Imaging Characteristics of Granulomas in Dogs

86 Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study.

87 Super-Resolution Whole-Brain 3D MR Spectroscopic Imaging for Mapping D-2-Hydroxyglutarate and Tumor Metabolism in Isocitrate Dehydrogenase 1-mutated Human Gliomas.

88 Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.

89 MicroRNA-129 Inhibits Glioma Cell Growth by Targeting CDK4, CDK6, and MDM2.

90 Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report.

91 Signaling Determinants of Glioma Cell Invasion.

92 Cytoskeleton and Nucleotide Signaling in Glioma C6 Cells.

93 Lipid Fraction Derived From MRI In- and Opposed-Phase Sequence as a Novel Biomarker for Predicting Survival Outcome of Glioma.

94 Adenosine Signaling in Glioma Cells.

95 Cytotoxic and apoptotic effects of ethanolic propolis extract on C6 glioma cells.

96 Clinical Aspects of SDHA-Related Pheochromocytoma and Paraganglioma: A Nationwide Study.

97 Low and high grade glioma segmentation in multispectral brain MRI data

98 Radiomic profiles in diffuse glioma reveal distinct subtypes with prognostic value.

99 A comprehensive analysis of the angiogenesis-related genes in glioblastoma multiforme vs. brain lower grade glioma.

100 Applications of magnetoliposomes with encapsulated doxorubicin for integrated chemotherapy and hyperthermia of rat C6 glioma.

101 Immune-Checkpoint Blockade and Active Immunotherapy for Glioma